Your browser doesn't support javascript.
loading
Glucose metabolism reprogramming promotes immune escape of hepatocellular carcinoma cells.
Zhang, Qiuyue; Liu, Jinchen; Lin, Haifeng; Lin, Bo; Zhu, Mingyue; Li, Mengsen.
Afiliación
  • Zhang Q; Hainan Provincial Key Laboratory of Carcinogenesis and Intervention, Hainan Medical College, Haikou 571199, Hainan Province, China.
  • Liu J; Hainan Provincial Key Laboratory of Carcinogenesis and Intervention, Hainan Medical College, Haikou 571199, Hainan Province, China.
  • Lin H; Department of Medical Oncology, Second Affiliated Hospital, Hainan Medical College, Haikou 570216, Hainan Province, China.
  • Lin B; Hainan Provincial Key Laboratory of Carcinogenesis and Intervention, Hainan Medical College, Haikou 571199, Hainan Province, China.
  • Zhu M; Hainan Provincial Key Laboratory of Carcinogenesis and Intervention, Hainan Medical College, Haikou 571199, Hainan Province, China.
  • Li M; Hainan Provincial Key Laboratory of Carcinogenesis and Intervention, Hainan Medical College, Haikou 571199, Hainan Province, China.
Explor Target Antitumor Ther ; 4(3): 519-536, 2023.
Article en En | MEDLINE | ID: mdl-37455832
ABSTRACT
Hepatocellular carcinoma (HCC) is a complex process that plays an important role in its progression. Abnormal glucose metabolism in HCC cells can meet the nutrients required for the occurrence and development of liver cancer, better adapt to changes in the surrounding microenvironment, and escape the attack of the immune system on the tumor. There is a close relationship between reprogramming of glucose metabolism and immune escape. This article reviews the current status and progress of glucose metabolism reprogramming in promoting immune escape in liver cancer, aiming to provide new strategies for clinical immunotherapy of liver cancer.
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Explor Target Antitumor Ther Año: 2023 Tipo del documento: Article País de afiliación: China

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Explor Target Antitumor Ther Año: 2023 Tipo del documento: Article País de afiliación: China
...